MENU
AIMS
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

AIMS stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Small Blend
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for AIMS with price predictions
Nov 20, 2026

AIMS's RSI Oscillator stoops into oversold zone

The RSI Indicator for AIMS moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where AIMS advanced for three days, in 25 of 36 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

AIMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AIMS as a result. In 7 of 10 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for AIMS turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In 6 of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

AIMS moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

The investment seeks long-term capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets (plus any borrowings made for investment purposes) in small-capitalization companies. The management defines small-capitalization (“small cap”) companies as those companies with a market capitalization, at the time of initial investment, that is equal to or smaller than the largest company in the Russell 2000® Index. The fund is non-diversified.

Market Cap

The average market capitalization across the Acuitas Small Cap Active ETF (AIMS) ETF is 1.93B. The market cap for tickers in the group ranges from 59.96M to 10.14B. CUBE holds the highest valuation in this group at 10.14B. The lowest valued company is MKTW at 59.96M.

High and low price notable news

The average weekly price growth across all stocks in the Acuitas Small Cap Active ETF (AIMS) ETF was -7%. For the same ETF, the average monthly price growth was -7%, and the average quarterly price growth was -7%. OFRM experienced the highest price growth at 26%, while HY experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Acuitas Small Cap Active ETF (AIMS) ETF was 46%. For the same stocks of the ETF, the average monthly volume growth was 40% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 51
Price Growth Rating: 54
SMR Rating: 65
Profit Risk Rating: 74
Seasonality Score: 7 (-100 ... +100)
AIMS's RSI Oscillator stoops into oversold zone